THROMBOTECT – a randomized study comparing low molecular weight heparin, antithrombin and unfractionated heparin for thromboprophylaxis during induction therapy of acute lymphoblastic leukemia in children and adolescents
THROMBOTECT Study Investigators
- University of Kiel
- Hannover Medical School
- University of Freiburg
- German Red Cross Blood Transfusion Service, Institute Oldenburg
- Städtisches Klinikum Braunschweig
- University of Cologne
- Zurich Center for Integrative Human Physiology (ZIHP)
- Klinikum Augsburg
- RWTH Aachen University
- Otto von Guericke University Magdeburg
- HELIOS Klinikum Erfurt
- University of Lausanne
- Charite - Universitatsmedizin Berlin
- Center for Laboratory Medicine and Hemostasis and Hemophilia Center
106
Link opens in a new tab
Citations
(Scopus)